Floatz logo

Verdiperstat

Multiple System Atrophy, Parkinson Variant (Disorder)

Brigham and Women's HospitalSmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Multiple System Atrophy, Parkinson Variant (Disorder) cohort.

Asset / SponsorPhaseRating
LEVODOPA
Julien Bally
Phase 1/2CCC
carbidopa
Julien Bally
Phase 1/2CCC
PBR-06
Brigham and Women's Hospital
Early Phase 1CC
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Indonesia University
N/AD

Same molecule, other indications

Verdiperstat is also rated in:

Parkinson diseaseDormant
B
Indicative ·
61 / 100
View asset →
amyotrophic lateral sclerosisDormant
CCC
Indicative ·
55 / 100
View asset →
semantic dementiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →